Pyridines, pyrimidines, and pyrazines, as BTK inhibitors and uses thereof
US10005784B2 · kind B2 · utility
0Cited by
8References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 27, 2017 |
| Grant date | Jun 26, 2018 |
| Priority date | — |
| Expiry date | Apr 27, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to pyridine, pyrimidine, and pyrazine compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.